{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-067474","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.473121+00:00","generated_at":"2026-05-18T01:19:24.092423+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Incannex appoints Dr. Gamaldo to OSA advisory board; Phase 2 data due next week","bullets":["Dr. Charlene E. Gamaldo (Johns Hopkins professor) joins IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.","Phase 2 data readout for IHL-42X expected next week, per CMO Dr. Lou Barbato.","Gamaldo has joint appointments in neurology, psychiatry, nursing, anesthesiology, and public health.","She has authored >120 scholarly works and received multiple sleep medicine leadership awards.","Appointment reflects Incannex's growing confidence in IHL-42X and commitment to scientific rigor."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-067474","json":"https://secwatch.observer/filing/0001213900-25-067474.json","markdown":"https://secwatch.observer/filing/0001213900-25-067474.md","text":"https://secwatch.observer/filing/0001213900-25-067474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/0001213900-25-067474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/ea0250114-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T01:19:24.092423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}